Megane Buttignol

Megane Buttignol

Auto-generated profile, based on publicly available information

Megane Buttignol

Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2025 in European Journal of Breast Health
Verified
Journal Article
Open access
PDF file
TOTolga Ozmen
Tolga Ozmen
CBCaroline BOUCHE
Caroline BOUCHE
MBMegane Buttignol
Megane Buttignol
BABolivar Arboleda-Osorio
Bolivar Arboleda-Osorio
MCMauricio Magalhaes Costa
Mauricio Magalhaes Costa
CMCAROLE MATHELIN
CAROLE MATHELIN
What Changes are Mandatory in Breast Surgery Training? An International Survey and Recommendations of the French Academy of Surgery and the Senologic International Society - European Journal of Breast Health

4 August 2025 in European Journal of Breast Health
Verified
Journal Article
Open access
CBCaroline BOUCHE
Caroline BOUCHE
WTWOLF Thibaut
WOLF Thibaut
MBMégane Buttignol
Mégane Buttignol
CMCAROLE MATHELIN
CAROLE MATHELIN
Pseudoangiomatous stromal hyperplasia (PASH) is a benign breast lesion frequently discovered incidentally during imaging or biopsy for other conditions. We present two cases of PASH associated with fibroadenomas in premenopausal women, both presenting as palpable, symptomatic breast masses. In the first case, a 26-year-old woman exhibited a 5.2 cm hypoechoic lesion, initially diagnosed as PASH on core biopsy, later confirmed as fibroadenoma with PASH components post-excision. The second case involved a 37-year-old woman with a painful 5.6 cm mass, diagnosed similarly via biopsy, and later confirmed as fibroadenoma fully colonized by PASH after surgical removal. Both cases highlight the diagnostic challenge in distinguishing PASH from fibroadenomas, given overlapping clinical and imaging features. Hormonal factors, particularly contraceptive use, may contribute to PASH development. Management remains controversial, with surgery indicated for symptomatic lesions, while conservative approaches may suffice for smaller, asymptomatic cases. Based on our findings and current literature, we propose a management algorithm to guide clinicians in differentiating cases warranting surgical intervention from those suitable for monitoring. Further studies are needed to validate this approach.

11 March 2023 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
MBMegane Buttignol
Megane Buttignol
EFEmilie Faller
Emilie Faller
LLLise Lecointre
Lise Lecointre
TBThomas Boisrame
Thomas Boisrame
CACherif Akladios
Cherif Akladios

29 July 2023 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
LLLise Lecointre
Lise Lecointre
MBMegane Buttignol
Megane Buttignol
EFEmilie Faller
Emilie Faller
TBThomas Boisrame
Thomas Boisrame
CMCamille Martel
Camille Martel
CACherif Akladios
Cherif Akladios

25 March 2026 in Clinical Surgical Oncology
Verified
Journal Article
Open access
MBMegane Buttignol
Megane Buttignol
CBCaroline Bouche
Caroline Bouche
TOTolga Ozmen
Tolga Ozmen
CMCarole Mathelin
Carole Mathelin

5 September 2025 in European Journal of Breast Health
Verified
Journal Article
Open access
PDF file
MBMegane Buttignol
Megane Buttignol
CBCaroline BOUCHE
Caroline BOUCHE
MCManon Chrétien
Manon Chrétien
NTNicolas Taris
Nicolas Taris
TOTolga Ozmen
Tolga Ozmen
CMCAROLE MATHELIN
CAROLE MATHELIN
Hemochromatosis: A Risk Factor for Breast Cancer? Systematic Review and Meta-Analysis - European Journal of Breast Health